Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.21.2
Stockholders' Equity (Tables)
 3 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Schedule of sales through equity offering program
Three months ended   Avg price
per share		     Number of
Shares		     Gross
Proceeds
(in millions)		     Offering
Expenses
(in millions)		     Net
Proceeds
(in millions)		  
September 30, 2021   $ 9.99       555,455     $           5.5     $        0.1     $         5.4  
Total             555,455     $ 5.5     $ 0.1     $ 5.4  

 
Schedule of Black-Scholes option pricing model with weighted average assumptions
    Three Months
Ended
September 30,
2021		  
Exercise price   $ 9.18 –10.15  
Expected term (years)     4.75 – 5.00  
Volatility     67 %
Risk-free interest rate     0.76%–0.81 %
Dividend yield     0 %
Weighted Average Grant Date Fair Value of Options granted during the period   $ 5.53  

  
Schedule of stock-based compensation expense
    Three Months Ended
September 30,		  
    2021     2020  
Research and Development   $ 1,232     $       1,014  
General and Administrative     1,116       1,013  
Total   $ 2,348     $ 2,027  

 
Schedule of unrecognized stock-based compensation expense and weighted-average years
    As of September 30, 2021  
    Unrecognized
stock-based
compensation		     Weighted-
average years
to be recognized		  
Options   $        4,056               2.55  
Restricted stock units   $ 12,386       2.51